- Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
-
Kim CM, Shin SH
- KMID: 1779132
- J Korean Med Sci.
- 2009 Apr;24(2):289-295.
- doi: 10.3346/jkms.2009.24.2.289
The standard iron-chelator deferoxamine is known to prevent the growth of coagulase-negative staphylococci (CoNS) which are major pathogens in iron-overloaded patients. However, we found that deferoxamine rather promotes the growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
-
Kim DS, Na YJ, Kang MH, Yoon SY, Choi CW
- KMID: 2373811
- Korean J Intern Med.
- 2016 Mar;31(2):357-366.
- doi: 10.3904/kjim.2015.024
BACKGROUND/AIMS: The treatment of chronic myeloid leukemia (CML) has achieved impressive success since the development of the Bcr-Abl tyrosine kinase inhibitor, imatinib mesylate. Nevertheless, resistance to imatinib has been observed,... -
- CITED
-
- Close
- SHARE
-
- Close
- Iron chelator inducesMIP-3alpha/CCL20 in human intestinal epithelial cells: implication for triggeringmucosal adaptive immunity
-
Lee HJ, Choi SC, Choi EY, Lee MH, Seo GS, Kim EC, Yang BJ, Lee MS, Shin YI, Park KI, Jun CD
- KMID: 1093465
- Exp Mol Med.
- 2005 Aug;37(4):297-310.
A previous report by this laboratory demonstrated that bacterial iron chelator (siderophore) triggers inflammatory signals, including the production of CXC chemokine IL-8, in human intestinal epithelial cells (IECs). Microarray-based gene... -
- CITED
-
- Close
- SHARE
-
- Close
